Specifically, we found that ACAT1 acts as a potential mLSTase, which affected the Ksucc level of mitochondrial metabolism–related enzymes and enhanced the mitochondrial oxidative metabolism of NSCLC, subsequently blocking the formation of TLS in a ROS-dependent manner, and promoting tumor progression. The gene discussed is ACAT1; the disease is neoplasm.